RYNE Biotechnology Inc. — Form D
RYNE Biotechnology Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-20. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-07-20
- Form: D
- Accession: 0001938657-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2022-06-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-453162
Issuer
- Name: RYNE Biotechnology Inc.
- CIK: 0001938657
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 815-505-6466
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Carter Cliff | Director | Cambridge, MA |
| Jonathan Yeh | Executive Officer | Cambridge, MA |
| David Fallace | Director | BOSTON, MA |
| Jeff Jonas | Director | Littleton, CO |
| Jeff Goater | Director | New York, NY |
| Peter Fuhrken | Director | Cambridge, MA |
| Howard Federoff | Director | Cambridge, MA |
| Howard Federoff | Executive Officer | Cambridge, MA |
| Nick Manusos | Director | Cambridge, MA |
| Nick Manusos | Executive Officer | Cambridge, MA |
| Martin Ostrowski | Executive Officer | Cambridge, MA |
| Jonathan Yeh | Director | Cambridge, MA |
Other filings by this issuer (1)
More